National Centre for Nuclear Research
PolandAll drugs from this manufacturer
-
This kit is intended for diagnostic purposes only. It allows the physician to detect areas in the body where there is an excess of somatostatin receptors, which helps in determining the best course of treatment.
Dosage form: powder for preparation of solution for injection
Active substance Dosage hynic-[d-phe1, tyr3-octreotide] 20 mcg ATC: V09IA07
-
It is a radiopharmaceutical drug used in renal diagnostics. It allows for the assessment of kidney function, blood flow, the presence of urinary tract obstructions, and filtration efficiency.
Dosage form: solution for injection
Active substance Dosage sodium iodohippurate 131 J ATC: V09CX02
-
The medicinal product is intended for adults, children, and adolescents for the treatment of thyroid nodules, hyperthyroidism, and large goiters (when no other treatment method is available).
Dosage form: capsules, hard
Active substance Dosage sodium iodide 37 - 7400 MBq ATC: V10XA01
-
The medicinal product is intended solely for the diagnosis of thyroid diseases. It is used to assess its size, shape, and function (e.g., hyperthyroidism or hypothyroidism), as well as to examine thyroid nodules and detect thyroid remnants or metastases in patients treated for differentiated thyroid cancer.
Dosage form: capsules, hard
Active substance Dosage sodium iodide do 37 MBq ATC: V09FX03
-
It is a radiopharmaceutical product that serves as a precursor for therapy. It is combined with another drug that reaches specific cells in the body to deliver small doses of ionizing radiation.
Dosage form: solution for radiopharmaceutical precursor
ATC: V10X
-
The medicinal product is used for the diagnosis and treatment of thyroid diseases, such as hyperthyroidism, hypothyroidism, goiter, or differentiated thyroid cancer. It is also used to assess the size, shape, and function of thyroid lesions (e.g., nodules).
Dosage form: solution for injection
Active substance Dosage sodium iodide i 131 37-740 MBq/ml -
The medicinal product is used in the treatment of mild thyroid diseases (such as multinodular goiter, hyperthyroidism in Graves' disease, or thyroid nodules) and in the treatment of differentiated thyroid cancer (to destroy remaining tissue after surgery, destroy tumor foci, or treat metastases).
Dosage form: capsules, hard
Active substance Dosage sodium iodide i-131 from 37 MBq to 5500 MBq ATC: V09XA
-
It is a radiopharmaceutical product used for therapeutic purposes. It only acts after being combined with another drug that reaches specific cells in the body, delivering small doses of radiation to them.
Dosage form: solution for radiopharmaceutical precursor
Active substance Dosage lutetium (177lu) chloride 0,925 - 37 GBq ATC: V10X
-
It is a radiopharmaceutical used in cancer diagnostics. It helps to detect, localize, and assess the stage of neuroendocrine tumors (e.g., pheochromocytoma, neuroblastoma, ganglioneuroblastoma, or medullary thyroid carcinoma) and to confirm their nature.
Dosage form: solution for injection
Active substance Dosage meta-iodo[131i]benzylguanidine sulfate 10-37 MBq/ml ATC: V09IX02
-
The medicinal product is used in cancer therapy to treat disseminated metastatic lesions of malignant pheochromocytoma, paraganglioma, neuroblastoma, ganglioneuroblastoma, and occasionally medullary thyroid carcinoma.
Dosage form: solution for injection
Active substance Dosage meta-iodo[131i]benzylguanidine sulfate 370-740 MBq/ml ATC: V10XA02
-
This is a medicinal product (radiopharmaceutical) used exclusively for diagnostic purposes. It is used for the localization of chromaffin tumors, paragangliomas, and ganglioneuromas, as well as for the detection and assessment of the stage of neuroblastomas. It also allows for the functional examination of the adrenal medulla and the myocardium.
Dosage form: solution for injection
Active substance Dosage meta iodobenzylguanidine sulfate not less than 18.5 MBq/ml ATC: V09IX01
-
This is a product intended for diagnostic use only. It is used to obtain a solution used in examinations of, among others, the thyroid, salivary glands, stomach, intestines, brain, heart, blood vessels, and tear ducts.
Dosage form: radionuclide generator
Active substance Dosage sodium chloride 9 mg/ml sodium pertechnetate tc 99m 0,5 - 15,0 GBq/ml sodium molybdate 99 mo 4 - 200 GBq water for injections No input provided ATC: V09FX01
-
This is a radiopharmaceutical preparation used exclusively for diagnostic imaging (scintigraphy) of the kidneys and brain, as well as for blood flow studies (angioscintigraphy).
Dosage form: powder for preparation of solution for injection
ATC: V09CA01
-
This is a product intended for diagnostic use only. When combined with the appropriate isotope, it is used for the examination of the liver and spleen.
Dosage form: powder for preparation of solution for injection
Active substance Dosage stannous chloride dihydrate 0.17 mg ATC: V09DB04
-
It is a preparation used in renal imaging diagnostics. It allows, among other things, for the determination of kidney location, their functional mass, and the examination of their structure and function.
Dosage form: kit for preparation of radiopharmaceutical preparation
ATC: V09CA02
-
It is a preparation used in diagnostic imaging (scintigraphy) of the liver and bile ducts.
Dosage form: powder for preparation of solution for injection
Active substance Dosage mbrida 20 mg ATC: V09DA04
-
It is a radiopharmaceutical preparation used exclusively for diagnostic imaging (scintigraphy) of the skeletal system.
Dosage form: powder for preparation of solution for injection
ATC: V09BA02
-
It is a radiopharmaceutical product used for diagnostic imaging. It is used to examine heart function and myocardial blood flow (e.g., to detect infarction or ischemia), for breast examination (when cancer is suspected), and to detect the location of hyperactive parathyroid glands.
Dosage form: kit for preparation of radiopharmaceutical preparation
Active substance Dosage mibi 1 mg ATC: V09GA01
-
This is a product intended solely for diagnostic purposes. It is used to perform imaging (scans) of various parts of the body, such as the thyroid, salivary glands, lacrimal ducts of the eyes, or for detecting Meckel's diverticulum. These images show the structure and functional efficiency of a given organ.
Dosage form: radionuclide generator
Active substance Dosage sodium molybdate [99mo] 9,1 - 200 GBq sodium pertechnetate [99mtc] 8,0 - 175 GBq ATC: V09FX01
-
This is a product intended exclusively for diagnostic use during scintigraphy examinations. It allows, among other things, for the study of heart function, imaging of organ perfusion, localization of gastrointestinal bleeding, blood volume measurement, and spleen scintigraphy.
Dosage form: powder for preparation of solution for injection
Active substance Dosage sodium pyrophosphate decahydrate 13.4 mg ATC: V09GA06
-
The medicinal product is used in the treatment of polycythemia vera and essential thrombocythemia (if other methods have failed), in the treatment of leukemia, and other blood disorders. It may also be used to relieve pain caused by bone metastases from cancer.
Dosage form: solution for injection
Active substance Dosage sodium phosphate 37 - 370 MBq/ml ATC: V10XX01
-
The medicinal product is used to relieve pain resulting from cancer metastases to the skeletal system, most commonly originating from the prostate or breast.
Dosage form: solution for injection
Active substance Dosage strontium chloride (89sr) 37.5 MBq/ml ATC: V10BX01
-
This is a product intended for diagnostic purposes only. It is used to visualize abnormal tissues and tumors in the stomach, intestine, and pancreas.
Dosage form: kit for preparation of radiopharmaceutical preparation
Active substance Dosage hynic-[d-phe1,tyr3-octreotide] trifluoroacetate 20 mcg ATC: V09IA07